COVID-19 vaccine won't increase immunity in organ transplant patients: Johns Hopkins University study | India News

Highlights
The story shows that just 54% of people who have received solid organ transplants produced sufficient antibodies.
New Delhi: Patients, who had organ transplants, remain vulnerable to COVID-19 infections even after a second vaccine dose, finds a study that urges people who are immunocompromised to strictly adhere to wearing masks, and maintain physical distancing, even after vaccination.
The study, led by researchers at Johns Hopkins University in the US, showed that after two doses of Moderna or Pfizer-BioNTech vaccine against SARS-CoV-2,  the virus that causes COVID 19, just 54 per cent of people who have received solid organ transplants produced sufficient antibodies. The findings are published in the Journal of the American Medical Association (JAMA).

Related Keywords

United States ,New Delhi ,Delhi ,India ,American ,Brian Boyarsky ,Johns Hopkins University ,Johns Hopkins School Of Medicine ,Journal Of The American Medical Association ,American Medical Association ,Dorry Segev ,Johns Hopkins School ,ஒன்றுபட்டது மாநிலங்களில் ,புதியது டெல்ஹி ,டெல்ஹி ,இந்தியா ,அமெரிக்கன் ,ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் ,ஜான்ஸ் ஹாப்கின்ஸ் பள்ளி ஆஃப் மருந்து ,இதழ் ஆஃப் தி அமெரிக்கன் மருத்துவ சங்கம் ,அமெரிக்கன் மருத்துவ சங்கம் ,ஜான்ஸ் ஹாப்கின்ஸ் பள்ளி ,